Abstract
Some infectious diseases, including COVID-19, can be transmitted via aerosols that are emitted by an infectious person and inhaled by susceptible individuals. Although physical distancing effectively reduces short-range airborne transmission, many infections have occurred when sharing room air despite maintaining distancing. We propose two simple parameters as indicators of infection risk for this situation. They combine the key factors that control airborne disease transmission indoors: virus-containing aerosol generation rate, breathing flow rate, masking and its quality, ventilation and air cleaning rates, number of occupants, and duration of exposure. COVID-19 outbreaks show a clear trend in relation to these parameters that is consistent with an airborne infection model, supporting the importance of airborne transmission for these outbreaks. The observed trends of outbreak size vs. risk parameters allow us to recommend values of the parameters to minimize COVID-19 indoor infection risk. All of the pre-pandemic spaces are in a regime where they are highly sensitive to mitigation efforts. Measles outbreaks occur at much lower risk parameter values than COVID-19, while tuberculosis outbreaks are observed at much higher risk parameter values. Since both diseases are accepted as airborne, the fact that COVID-19 is less contagious than measles does not rule out airborne transmission. It is important that future outbreak reports include ventilation information, to allow expanding our knowledge of the circumstances conducive to airborne transmission of different diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
ZP and JLJ were partially supported by NSF AGS-1822664. TG was supported by ESRC ES/V010069/1.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is a modeling study. Data were computationally generated.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is available in the main text or the Supporting Information.
